US Steel Issues Weak Q4 Outlook, Joins Novo Nordisk And Other Big Stocks Moving Lower In Friday's Pre-Market Session
US Steel Issues Weak Q4 Outlook, Joins Novo Nordisk And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Friday.
美國股票期貨今晨下跌,道瓊斯期貨在週五下跌超過100點。
Shares of United States Steel Corporation (NYSE:X) fell sharply in today's pre-market trading after the company issued fourth-quarter adjusted EPS guidance below analyst estimates.
美國鋼鐵公司(紐交所:X)的股票在今天的美股盤前交易中大幅下跌,因爲該公司發佈了第四季度調整後每股收益指引,低於分析師預期。
After the market close on Thursday, U.S. Steel said it expects to report a fourth-quarter adjusted loss of 25 cents to 29 cents per share. Fourth-quarter adjusted EBITDA is expected to come in around $150 million.
在週四市場收盤後,美國鋼鐵表示預計第四季度調整後每股損失在25美分到29美分之間。第四季度調整後 EBITDA 預計約爲15000萬美元。
U.S. Steel shares dipped 6.5% to $29.65 in the pre-market trading session.
美國鋼鐵的股票在美股盤前交易中下跌了6.5%,至29.65美元。
Here are some other stocks moving lower in pre-market trading.
以下是一些在美股盤前交易中也有下跌的其他股票。
- Novo Nordisk A/S (NYSE:NVO) fell 25.8% to $76.80 in pre-market trading. Novo Nordisk said CagriSema demonstrated weight loss in adults with obesity or overweight in the REDEFINE 1 trial.
- Innovative Industrial Properties, Inc. (NYSE:IIPR) dipped 19.1% to $77.10 in pre-market trading after the company reported a default by Pharmacann on its obligations to pay rent for six of its eleven leases in December.
- Mesoblast Limited (NASDAQ:MESO) shares fell 18.1% to $13.72 in pre-market trading. Mesoblast shares jumped over 36% on Thursday after the company announced the FDA approved Ryoncilas the first mesenchymal stromal cell therapy in the United States.
- Quantum Computing Inc. (NASDAQ:QUBT) fell 11.1% to $13.46 in pre-market trading after declining 41% on Thursday.
- Arqit Quantum Inc. (NASDAQ:ARQQ) declined 7.2% to $24.98 in pre-market trading.
- Transportadora de Gas del Sur S.A. (NYSE:TGS) fell 5.4% to $26.01 in pre-market trading.
- 諾和諾德A/S(紐交所:NVO)在美股盤前交易中下跌25.8%,至76.80美元。諾和諾德表示,CagriSema在REDEFINE 1試驗中表現出對肥胖或超重成年人的減重效果。
- 創新工業物業公司(紐交所:IIPR)在美股盤前交易中下跌了19.1%,至77.10美元,因爲該公司報告了Pharmacann未能履行其12月六項租賃的租金支付義務。
- Mesoblast Limited(納斯達克:MESO)在美股盤前交易中下跌18.1%,至13.72美元。Mesoblast的股價在週四上漲超過36%,此前該公司宣佈FDA批准Ryoncil作爲美國首個間充質幹細胞療法。
- 量子計算公司(納斯達克:QUBT)在美股盤前交易中下跌11.1%,降至13.46美元,此前週四下跌了41%。
- Arqit Quantum Inc. (納斯達克:ARQQ) 在美股盤前交易中下跌了7.2%,至24.98美元。
- 阿根廷南部燃氣 S.A. (紐交所:TGS) 在美股盤前交易中下跌了5.4%,至26.01美元。
Now Read This:
現在閱讀這個:
- S&P 500, Nasdaq End In Red As Investor Sentiment Declines, Micron Tumbles After Sales Miss: Greed Index In 'Extreme Fear' Zone
- S&P 500、納斯達克收跌,投資者情緒下降,美光在銷售未達預期後暴跌:貪婪指數處於'極度恐懼'區域
譯文內容由第三人軟體翻譯。